ALB and type 2 diabetes mellitus: T2DM with HbA1c ≥6.5 and ≤12% with eGFR ≥30 and ≤90, Pt. need to be on maximum tolerated dose of ACEi or ARB 4 weeks prior to randomization, urine albumin to creatinine ratio >300mg/g and <5000mg/g N = 4401